Core Viewpoint - ZTO Express (02057) announced the issuance of $1.5 billion in notes, with a purchase price of 98.9% of the principal amount, scheduled for February 4, 2026 [1] Group 1: Notes Issuance Details - The company will sell $1.5 billion in notes to initial buyers, with the notes being offered to at least six independent allocators [1] - The notes will be priced at 100% of the principal amount plus any accrued interest from February 9, 2026 [1] - The initial conversion price is approximately $30.9473 per share, representing a 37.5% premium over the closing price of $22.51 per American Depositary Share on February 3, 2026 [1] Group 2: Estimated Proceeds and Share Conversion - The estimated net proceeds from the issuance are approximately $1.4041 billion, with the notes convertible into about 4.84695 million shares [1] - The net price per share for conversion is expected to be around $28.9692, based on the closing price of HKD 179.10 per A-class ordinary share [1] Group 3: Pricing and Share Buyback - The company has entered into capped call transactions with initial buyers, with the premium for these options being approximately $76.95 million, or about 5.1% of the total principal amount of the notes [2] - Concurrently, the company agreed to repurchase approximately 18.2544 million A-class ordinary shares, representing about 2.29% of the shares outstanding as of February 3, 2026, and about 37.66% of the convertible shares [2]

Market Overview - AMD's overnight drop of 17% triggered a significant decline in chip stocks, leading to a 1.95% drop in the Chinese concept index, which negatively impacted the Hong Kong stock market [1] - The Hang Seng Index fell by 340.88 points, or 1.27%, to 26,506.44 points, while the Hang Seng Tech Index decreased by 62.30 points, or 1.16%, to 5,304.14 points [1] - Major tech stocks like Tencent and Alibaba saw declines of nearly 3% and 2.5%, respectively, with Tencent's market value dropping below 500 billion [1] Company Performance - Xinda Biopharmaceuticals (01801.HK) projected total product revenue of approximately RMB 11.9 billion for 2025, reflecting a year-on-year growth of about 45% [2] - Lee & Man Paper Manufacturing (02314.HK) expects profits for 2025 to be between HKD 1.88 billion and HKD 2.00 billion, indicating a year-on-year increase of 38% to 47% [2] - ZTO Express (02057.HK) anticipates total revenue of RMB 48.5 billion to RMB 50 billion for 2025, representing a year-on-year growth of approximately 9.5% to 12.9% [2] - China Resources Cement (01313.HK) forecasts a year-on-year profit increase of about 115% to 135% for 2025, driven by reduced costs and impairment losses [2] Corporate Actions - Goldin Properties (00535.HK) reported a January contract sales total of approximately RMB 239 million, a year-on-year decrease of 61.82% [3] - Fosun International (00656.HK) plans to subscribe for additional registered capital of RMB 105 million in Shangmeng Technology, acquiring a 51.0879% stake post-increase [3] - Shanghai Pharmaceuticals (02607.HK) intends to publicly transfer its 30% stake in Bristol-Myers Squibb, with a minimum listing price of approximately RMB 1.023 billion [3] - China Coalbed Methane (08270.HK) completed the sale of 100% equity in Shanxi Qingshui Shuntai Energy Development [4] Investment Trends - The active repurchase of shares continues, with Kingsoft (03888.HK) repurchasing 1.0886 million shares for approximately HKD 29.99 million [9] - Xiaomi Group (01810.HK) repurchased 4.3 million shares for a total of HKD 146 million [10] - Kingdee International (00268.HK) repurchased 1 million shares for approximately HKD 11.1 million [11] Market Outlook - Guoyuan International's report suggests that the Hong Kong stock market may experience short-term volatility due to external factors, but maintains a positive long-term outlook [12] - CITIC Securities highlights the potential for new investment opportunities in emerging markets, despite risks from rising oil prices and long-term bond yields [12] - Galaxy Securities recommends focusing on technology, energy, precious metals, and consumer sectors for potential rebounds [13]

智通财经APP获悉，港股恒生指数跌1.27%，跌340点，报26506点；恒生科技指数跌1.16%。港股早盘成 交1683亿港元。 腾讯控股（00700）股价跌2.87%，市值跌破5万亿港元。 名创优品(09896)逆市涨超5%，首度与央视总台春晚进行合作，"兴趣消费"战略迎关键性跃升。 巨子生物(02367)盘中涨超4%，全球首个注射用重组胶原蛋白和透明质酸钠复合溶液获批。 中通快递-W(02057)涨2.35%，2025年包裹量同比增长13.3%，拟溢价约37.5%发行15亿美元票据。 钧达股份(02865)回吐逾10%，行业协会发声太空光伏技术仍处探索初期。 煤炭股普遍回落。兖煤澳大利亚(03668)、首钢资源(00639)均跌超6%。 隔夜AMD暴跌影响芯片股。华虹半导体(01347)跌超5%，兆易创新(03986)跌超5%。 黄金股再度走低。国际黄金市场波动加剧，机构称贵金属根本逻辑并未改变。中国黄金国际(02099)跌 6.8%；紫金矿业(02899)跌6%。 餐饮股涨幅居前，餐饮行业经营态势持续回暖，机构称龙头企业率先凸显配置价值。百胜中国(09987) 涨8.7%；海底捞(06862)涨2.5 ...

Group 1: Insurance Sector - Insurance stocks are experiencing significant declines, with China Life (02628) down 3.75%, New China Life (01336) down 3.28%, and China Pacific Insurance (02601) down 2.74%. The government plans to issue approximately 200 billion yuan in special bonds to inject capital into major insurance companies, marking the first time this method will be used for insurance firms in China [1] Group 2: Logistics and Delivery - ZTO Express (02057) has seen an increase of over 2.3%. The company estimates that its total revenue for 2025 will be between 48.5 billion yuan and 50 billion yuan, representing a growth of approximately 9.5% to 12.9% compared to 44.2807 billion yuan in 2024 [1] Group 3: Biotechnology - Innovent Biologics (09969) has risen over 4%, with a current increase of 3.25%. The company anticipates achieving revenue of 2.37 billion yuan in 2025, a year-on-year growth of approximately 134%, and expects to turn a profit with a net profit of around 630 million yuan [1] Group 4: Coal Sector - Coal stocks are generally declining, with Yancoal Australia (03668) down 6.63%, Shougang Resources (00639) down 7.83%, and China Shenhua (01088) down 2.47%. This decline follows reports that the Indonesian government has proposed a production cut plan, leading to a 40% to 70% reduction in production quotas for major miners [2] Group 5: Medical Devices - GigaGen (02367) has increased over 8%, currently up 4.11%. The company recently announced that its "recombinant type I α1 collagen and sodium hyaluronate composite solution" has been approved as a medical device, marking a significant milestone as the first product of its kind for improving facial smoothness [2] Group 6: Semiconductor Sector - Semiconductor stocks are all declining, with Hua Hong Semiconductor (01347) down 5.91% and SMIC (00981) down 3.49%. This follows a significant drop in AMD's stock price by 17.31% after its fourth-quarter report indicated that while revenue exceeded expectations, the guidance for the first quarter was below market expectations [3] Group 7: Restaurant Sector - Restaurant stocks are performing well, with Yum China (09987) up 8.41% and Haidilao (06862) up 2.69%. The restaurant industry has shown signs of recovery, with retail sales in the sector growing by 3.8%, 3.2%, and 2.2% year-on-year in the last quarter of 2025, significantly outpacing overall retail growth [3] Group 8: Consumer Goods - Miniso (09896) has risen over 5.1% after announcing its partnership with the Central Radio and Television Station for the 2026 Spring Festival Gala. This collaboration is seen as a significant marketing move to elevate the brand's visibility in the mainstream market [4] Group 9: Gold Sector - Gold stocks are declining, with China Gold International (02099) down 6.8% and Zijin Mining (02899) down 6.29%. Recent volatility in the international gold market has been noted, with expectations that geopolitical tensions and liquidity easing by the Federal Reserve may drive gold prices higher [4] Group 10: Cryptocurrency - Cryptocurrency ETFs and related stocks are continuing to decline, with significant drops in prices, including Bitcoin falling below $72,000 for the first time in 15 months. The price has decreased by over 42% from its peak last October [5] Group 11: US Market Highlights - Boston Scientific (BSX.US) fell 17.59% after providing lower-than-expected guidance for fiscal year 2026. The company expects adjusted earnings per share to be between $3.43 and $3.49, slightly below analyst expectations [6] - Solar stocks surged, with Enphase Energy (ENPH.US) rising 38.6% following reports of interest from Elon Musk's teams in the Chinese solar supply chain [6]

每日晨报│2026 年 2 月 5 日 -主要市场指数表现 | | 收市价 | 上个交易日升 | YTD 升跌 | | --- | --- | --- | --- | | 恒生指数 | 26,847 | +0.05% | +4.75% | | 恒生科技指数 | 5,366 | -1.84% | -2.71% | | 国企指数 | 9,048 | -0.05% | +1.51% | | 沪深 300 | 4,698 | +0.83% | +1.48% | | 上证综合指数 | 4,102 | +0.85% | +3.36% | | 深证成份指数 | 14,156 | +0.21% | +4.67% | | 中小板指 | 8,526 | +0.02% | +3.18% | | 道琼斯指数 | 49,501 | +0.53% | +2.99% | | 标普 500 指数 | 6,882 | -0.51% | +0.54% | | 纳斯达克指数 | 22,904 | -1.51% | -1.45% | | 伦敦富时指数 | 10,402 | +0.85% | +4.74% | | CAC40 指数 | 8,262 | ...

Group 1 - The core viewpoint of the article is that ZTO Express plans to issue $1.5 billion in convertible preferred notes while simultaneously repurchasing shares, which may lead to a resumption of its buyback program during the upcoming earnings release [1] - ZTO Express has a remaining buyback capacity of $700 million until September 2025, indicating potential for future share repurchases [1] - The report suggests that low interest rates and reasonable premiums can fully offset any potential dilution effects from the issuance of convertible notes, leading to a mildly positive outlook on the issuance [1] Group 2 - ZTO Express reported a preliminary performance for 2025, with package volume growth of 13.3%, aligning with expectations [1] - The company's revenue is projected to be between 48.5 billion and 50 billion yuan, with gross profit estimated between 12.15 billion and 12.55 billion yuan, both of which are roughly in line with expectations from the bank and the market [1] - The bank maintains a "Buy" rating for ZTO Express on the US stock market, with a target price set at $22.6 [1]

每经AI快讯，中通快递-W(02057.HK)涨近3%，截至发稿，涨2.74%，报184港元，成交额3.21亿港元。 （文章来源：每日经济新闻） ...

（原标题：港股速报 | 港股低开 百胜中国公布年报 净利润增长11% 股价涨超8%） 今日（2月5日），港股市场继续低开。 截至发稿，恒生指数开盘报26627.95点，下跌219.37点，跌幅0.82%。 百胜中国（HK09987）公布2025年全年业绩，受强劲财报影响，今日早盘百胜中国高开超4%，截至发稿涨幅超过8%，创出2023年10月以来新高。 恒生科技指数开盘报5295.89点，下跌70.55点，跌幅1.31%。 港股进入财报季，上市公司业绩备受市场关注。 全年来看，公司经营利润达到13亿美元，同比实现11%的强劲增长，2025年新增1706家新店，门店网络扩展至18101家，覆盖中国2500余座城镇。2025年第 四季度，百胜中国经营利润同比大幅提升25%，同店销售额连续第三个季度增长。 理文造纸（HK02314），预计于2025年取得盈利约18.8亿港元至20.0亿港元，同比增长38%至47%。 中通快递-W(HK02057)，预计2025年收入总额介于人民币485亿元至人民币500亿元，同比增长约9.5%至12.9%，主要由于包裹量增加。 百度集团（HK09888）发布公告，董事会批准一项新的股 ...

2月5日，中通快递-W拟溢价约37.5%发行15亿美元票据。花旗指出，由于截至2025年9月尚余7亿美元股 份回购额度，公司可能于近期业绩发布时重启回购计划。该行认为，低利率和合理溢价可完全抵销潜在 稀释影响，对发行可换股票据看法轻微正面。此外，中通快递公布2025年初步业绩，包裹量增长 13.3%，符合该行预期，营收区间为485-500亿元人民币，毛利介乎121.5-125.5亿元人民币，两者中位均 大致符合该行和市场预期。 消息面上，2月4日，中通快递-W发布公告，本公司估计：2025年，其收入总额介于人民币485亿元至人 民币500亿元，较2024年的人民币442.807亿元增长约9.5%至12.9%；及2025年，其毛利介于人民币121.5 亿元至人民币125.5亿元，较2024年的人民币137.17亿元减少约8.5%至11.4%。收入总额的估计增长主要 受包裹量由2024年的340.1亿件增加至2025年的385.2亿件(同比增长13.3%)所带动。 中通快递-W(02057)涨近3%，截至发稿，涨2.74%，报184港元，成交额3.21亿港元。 ...

智通财经APP获悉，中通快递-W(02057)涨近3%，截至发稿，涨2.74%，报184港元，成交额3.21亿港 元。 2月5日，中通快递-W拟溢价约37.5%发行15亿美元票据。花旗指出，由于截至2025年9月尚余7亿美元股 份回购额度，公司可能于近期业绩发布时重启回购计划。该行认为，低利率和合理溢价可完全抵销潜在 稀释影响，对发行可换股票据看法轻微正面。此外，中通快递公布2025年初步业绩，包裹量增长 13.3%，符合该行预期，营收区间为485-500亿元人民币，毛利介乎121.5-125.5亿元人民币，两者中位均 大致符合该行和市场预期。 消息面上，2月4日，中通快递-W发布公告，本公司估计：2025年，其收入总额介于人民币485亿元至人 民币500亿元，较2024年的人民币442.807亿元增长约9.5%至12.9%；及2025年，其毛利介于人民币121.5 亿元至人民币125.5亿元，较2024年的人民币137.17亿元减少约8.5%至11.4%。收入总额的估计增长主要 受包裹量由2024年的340.1亿件增加至2025年的385.2亿件(同比增长13.3%)所带动。 ...